-
Access to EU-Authorized Nonreimbursed Anticancer Medicines: An Explorative Survey Among Dutch Medical Oncologists
Post, H. C., Bomhof, C. H. C., Schermer, M., Hollak, C. E. M., van Laarhoven, H. W. M., Schutte, T. & Bunnik, E. M., Oct 2025, In: Clinical Therapeutics. 47, 10, p. 894-903 10 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Improving the usability of grading scales for drug-induced ototoxicity with a focus on real world data collection
Koot, M., Crul, M., van Balen, D. & Schutte, T., Jun 2025, In: European Archives of Oto-Rhino-Laryngology. 282, 6, p. 3343-3347 5 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Comparison of cisplatin-induced hearing loss in different durations of infusion and volume of hydration schedules in head and neck squamous cell carcinoma patients treated with cisplatin-based chemoradiation
Burger, A. V. M., Koot, M. A., van Balen, D. E. M., Schaeffers, A. W. M. A., Zuur, C. L., Devriese, L. A., Ridder, M. D., Hoetink, A. E., Schutte, T. & Crul, M., 1 May 2025, In: Oral oncology. 164, 107246.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
